» Articles » PMID: 38785550

Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2024 May 24
PMID 38785550
Authors
Affiliations
Soon will be listed here.
Abstract

This review systematizes information about the metabolic features of breast cancer directly related to oxidative stress. It has been shown those redox changes occur at all levels and affect many regulatory systems in the human body. The features of the biochemical processes occurring in breast cancer are described, ranging from nonspecific, at first glance, and strictly biochemical to hormone-induced reactions, genetic and epigenetic regulation, which allows for a broader and deeper understanding of the principles of oncogenesis, as well as maintaining the viability of cancer cells in the mammary gland. Specific pathways of the activation of oxidative stress have been studied as a response to the overproduction of stress hormones and estrogens, and specific ways to reduce its negative impact have been described. The diversity of participants that trigger redox reactions from different sides is considered more fully: glycolytic activity in breast cancer, and the nature of consumption of amino acids and metals. The role of metals in oxidative stress is discussed in detail. They can act as both co-factors and direct participants in oxidative stress, since they are either a trigger mechanism for lipid peroxidation or capable of activating signaling pathways that affect tumorigenesis. Special attention has been paid to the genetic and epigenetic regulation of breast tumors. A complex cascade of mechanisms of epigenetic regulation is explained, which made it possible to reconsider the existing opinion about the triggers and pathways for launching the oncological process, the survival of cancer cells and their ability to localize.

Citing Articles

Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer.

McMahon A, Reis I, Takita C, Wright J, Hu J Cancers (Basel). 2025; 17(5).

PMID: 40075737 PMC: 11899340. DOI: 10.3390/cancers17050891.


Role of oxeiptosis in disease mechanisms and therapeutic opportunities.

Bhuvaneshwari K, Harithpriya K, Ganesan K, Xu B, Ramkumar K Apoptosis. 2025; .

PMID: 40064755 DOI: 10.1007/s10495-025-02087-z.


Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study.

Ergas I, Cheng R, Roh J, Kresovich J, Iribarren C, Nguyen-Huynh M Breast Cancer Res Treat. 2025; .

PMID: 39890673 DOI: 10.1007/s10549-025-07629-2.


Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.

Dong R, Wang J, Guan R, Sun J, Jin P, Shen J Antioxidants (Basel). 2025; 14(1).

PMID: 39857438 PMC: 11760893. DOI: 10.3390/antiox14010104.


In Silico Analysis of Non-Conventional Oxidative Stress-Related Enzymes and Their Potential Relationship with Carcinogenesis.

Seiva F, Agneis M, de Almeida M, Caputo W, de Souza M, das Neves K Antioxidants (Basel). 2024; 13(11).

PMID: 39594421 PMC: 11591236. DOI: 10.3390/antiox13111279.


References
1.
Constance J, Lim C . Targeting malignant mitochondria with therapeutic peptides. Ther Deliv. 2012; 3(8):961-79. PMC: 3604891. DOI: 10.4155/tde.12.75. View

2.
Mense S, Remotti F, Bhan A, Singh B, El-Tamer M, Hei T . Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol. 2008; 232(1):78-85. PMC: 2593408. DOI: 10.1016/j.taap.2008.06.007. View

3.
Yang H, Villani R, Wang H, Simpson M, Roberts M, Tang M . The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018; 37(1):266. PMC: 6211502. DOI: 10.1186/s13046-018-0909-x. View

4.
Nour Eldin E, El-Readi M, Nour Eldein M, Alfalki A, Althubiti M, Mohamed Kamel H . 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer. Clin Breast Cancer. 2019; 19(2):e385-e393. DOI: 10.1016/j.clbc.2018.12.013. View

5.
Willhite C, Karyakina N, Yokel R, Yenugadhati N, Wisniewski T, Arnold I . Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol. 2014; 44 Suppl 4:1-80. PMC: 4997813. DOI: 10.3109/10408444.2014.934439. View